此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

USDA Western Human Nutrition Research Center (WHNRC) Cross-Sectional Nutritional Phenotyping Study

Assessing the Impact of Diet on Inflammation in Healthy and Obese Adults in a Cross-Sectional Phenotyping Study

Although the diet of the US population meets or exceeds recommended intake levels of most essential nutrients, the quality of the diet consumed by many Americans is sub-optimal due to excessive intake of added sugars, solid fats, refined grains, and sodium. The foundations and outcomes of healthy vs. unhealthy eating habits and activity levels are complex and involve interactions between the environment and innate physiologic/genetic background. For instance, emerging research implicates chronic and acute stress responses and perturbations in the Hypothalamic-Pituitary-Adrenal axis in triggering obesity-promoting metabolic changes and poor food choices. In addition, the development of many chronic diseases, including cardiovascular disease, diabetes, cancer, asthma and autoimmune disease, results from an overactive immune response to host tissue or environmental antigens (e.g. inhaled allergens). A greater understanding is needed of the distribution of key environment-physiology interactions that drive overconsumption, create positive energy balance, and put health at risk.

Researchers from the United States Department of Agriculture (USDA) Western Human Nutrition Research Center are conducting a cross-sectional "metabolic phenotyping" study of healthy people in the general population. Observational measurements include the interactions of habitual diet with the metabolic response to food intake, production of key hormones, the conversion of food into energy: the metabolism of fats, proteins, and carbohydrates, characteristics of the immune system, stress response, gut microbiota (bacteria in the intestinal tract), and cardiovascular health. Most outcomes will be measured in response to a mixed macronutrient/high fat challenge meal.

研究概览

地位

完全的

条件

详细说明

Many inflammatory responses can be modulated by specific dietary components. For example, in cardiovascular disease, macrophages and T-cells react with oxidized LDL (an endogenous modified antigen) to produce arterial plaque and subsequent blockage of coronary arteries. High intake of saturated fats (or simple sugars that drive synthesis of saturated fatty acids) may promote this inflammation by affecting macrophages and T-cells. Conversely, increased intake of omega-3 fatty acids may decrease inflammation by suppression of macrophage and T-cell pro-inflammatory activity. Long-term sub-clinical inflammation caused by intestinal bacteria has been linked to the development of Irritable Bowel Disease and related disorders. Low intake of fruits, vegetables, or whole grains or high intake of saturated fats may promote sub-clinical gut inflammation by promoting dysbiosis of the gut microbiota. Allergic asthma develops in predisposed individuals as a result of an overactive allergic-type immune response to inhaled environmental allergens. Dietary factors such as vitamin D and omega-3 fatty acids may diminish pro-inflammatory responses to environmental allergens by promoting the development of T-regulatory cells and other anti-inflammatory factors.

Individual variability in chronic disease risk is well recognized. For example, why does excess adiposity lead to disease in some individuals and not others? The nature of the fat tissue rather than the abundance, may impact cross-talk with other metabolically-relevant tissues and affect disease risk. It is important to characterize healthy vs. unhealthy phenotypes across various tissues and to understand how micro- and macro-nutrients interact with molecular and metabolic pathways to support a healthy body weight. This study brings together scientists with expertise in nutritional sciences, immunology, analytical chemistry, physiology, neuroendocrinology, and behavior to understand how diet impacts metabolism and disease risk through the interplay and coordination of signals and metabolites arising from multiple organ systems.

The overall objective is to characterize the phenotypic profile of participants according to their immunologic, physiologic, neuroendocrine, and metabolic responses to a dietary challenge and a physical fitness challenge by addressing the specific aims listed below. The cross-sectional study is organized into two study visits (Visit 1 and Visit 2) separated by approximately two weeks of at-home specimen and data collection.

Specific Aim 1: To determine if diet quality is independently associated with systemic immune activation, inflammation, or oxidative stress differentiated by:

  1. pro-inflammatory T-helper cells (Th1, Th2, and Th17 cells) and related cytokines
  2. anti-inflammatory T-regulatory cells and related cytokines
  3. dysbiosis of the gut microbiota and markers of gut inflammation (e.g. neopterin and myeloperoxidase)

    a. and to evaluate the association between dysbiosis of the gut microbiota, gut inflammation, and systemic immune activation

  4. plasma metabolomic response to a mixed macronutrient challenge meal (includes diet quality and physical activity as independent variables)
  5. endothelial (dys)function and vascular reactivity

Specific Aim 2: To determine if a high fat/sugar challenge meal induces differential effects over time (0-6h postprandial) according to habitual diet characteristics, physical activity levels, stress levels, age, sex, or BMI on:

  1. postprandial monocyte activation
  2. plasma lipid metabolomic responses including non-esterified fatty acids, phospholipids, triacylglycerols, red blood cell fatty acids, endocannabinoids, bile acids, eicosanoids and related oxylipins, ceramides, sphingoid bases, and acylcarnitines
  3. plasma amino acid metabolomics
  4. glucose metabolism and metabolic flexibility (i.e. the ability to switch from glucose to lipid oxidation as energy sources)
  5. changes in endocrinology and self-report of hunger and satiety
  6. postprandial free cortisol

Specific Aim 3: To determine the mechanisms of:

  1. postprandial monocyte activation
  2. suppression of challenge-meal induced monocyte activation by docosahexaenoic acid (DHA) (in an ex vivo experiment using a subset of samples)

Specific Aim 4: To evaluate the associations between eating behavior, physical activity, and/or anthropometry and the outcomes:

  1. endocrinology of hunger and satiety
  2. plasma metabolomic responses
  3. vulnerability and resistance to stress
  4. endothelial (dys)function and vascular reactivity
  5. prediction of insulin sensitivity

Specific Aim 5: To determine how genetic variants affect nutrient metabolism, cardiovascular physiology, and immune function and improve understanding of how dietary factors affect these metabolic, cardiovascular and immune phenotypes.

研究类型

观察性的

注册 (实际的)

393

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • California
      • Davis、California、美国、95616
        • USDA, Western Human Nutrition Research Center

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 65年 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

全部

取样方法

非概率样本

研究人群

Healthy people in the general population

描述

Inclusion Criteria:

  • 18-65 y
  • Male or female
  • Body Mass Index 18.5-45.0 kg/m2 (Normal to obese)

Exclusion Criteria:

  • Pregnant or lactating women
  • Known allergy to egg-white protein
  • Systolic blood pressure greater than 140 mm Hg or diastolic blood pressure greater than 90 mm Hg measured on three separate occasions
  • Diagnosed active chronic diseases for which the individual is currently taking daily medication, including but not limited to:

    • Diabetes mellitus
    • Cardiovascular disease
    • Cancer
    • Gastrointestinal disorders
    • Kidney disease
    • Liver disease
    • Bleeding disorders
    • Asthma
    • Autoimmune disorders
    • Hypertension
    • Osteoporosis
  • Recent minor surgery (within 4 wk) or major surgery (within 16 wk)
  • Recent antibiotic therapy (within 4 wk)
  • Recent hospitalization (within 4 wk)
  • Use of prescription medications at the time of the study that directly affect endpoints of interest (e.g. hyperlipidemia, glycemic control, steroids, statins, anti-inflammatory agents, and over-the-counter weight loss aids)

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
Sampling strata
Stratified analyses of primary and secondary outcomes based on variables of interest (e.g. sex, age, or BMI) may occur prior to achieving the target for total study enrollment.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Baseline level and change in systemic immune activation following challenge meal
大体时间:0, 0.5, 3, and 6 hours postprandial
Number and activation level of pro-inflammatory T-helper (Th) cells (Th1, Th2 and Th17), T-regulatory (Treg) cells, and B cells will be measured in fasting blood. Monocytes and neutrophils will be measured in fasting and postprandial blood.
0, 0.5, 3, and 6 hours postprandial
Baseline level and change in plasma metabolome
大体时间:0, 0.5, 3, and 6 hours postprandial
Plasma fatty acid profiles of non-esterified fatty acids, phospholipids, triacylglycerols, red blood cell fatty acids, endocannabinoids, bile acids, eicosanoids and related oxylipins, ceramides, sphingoid bases, acylcarnitines, amino acids and other metabolites measured in response to a challenge meal.
0, 0.5, 3, and 6 hours postprandial

次要结果测量

结果测量
措施说明
大体时间
Baseline level and change in glucose metabolism
大体时间:0, 0.5, 3, and 6 hours postprandial
Glucose and insulin measured in response to a challenge meal.
0, 0.5, 3, and 6 hours postprandial
Baseline level and change in appetitive hormones
大体时间:0, 0.5, 3, and 6 hours postprandial
Cholecystokinin, incretins, Peptide YY 3-36, ghrelin measured in response to a challenge meal.
0, 0.5, 3, and 6 hours postprandial
Baseline level and change in mitogen activated protein (MAP) kinase activity
大体时间:0, 0.5, 3 and 6 hours postprandial
Mononuclear cells or B cells will be measured for MAP kinase activities in fasting and postprandial blood.
0, 0.5, 3 and 6 hours postprandial
Baseline level and change in dietary-responsive, circulating microRNA
大体时间:0, 0.5, 3, and 6 hours postprandial
Plasma microRNA measured in response to a challenge meal
0, 0.5, 3, and 6 hours postprandial
Baseline level and change in RNA transcriptome
大体时间:0, 3, and 6 hours postprandial
Transcriptome RNA sequenced in whole blood
0, 3, and 6 hours postprandial
Genome Wide Association Study (GWAS)
大体时间:0 hours (fasting)
DNA sequence from whole blood will be analyzed
0 hours (fasting)
General health
大体时间:0 hours (Fasting)
Clinical chemistry panel and complete blood count
0 hours (Fasting)
Anthropometrics
大体时间:single time point
Height (cm), weight (kg), waist and hip circumference (cm)
single time point
Vital signs
大体时间:single time point
Blood pressure (mmHg), pulse rate (beats per minute) and temperature (degrees F).
single time point
Body composition
大体时间:single time point
Body composition (percent body fat) and bone mineral density by Dual energy X-ray Absorptiometry scan.
single time point
Resting and change in metabolism
大体时间:0, 0.5, 3, and 6 hours postprandial
Resting and postprandial metabolic rates, including respiratory exchange ratios.
0, 0.5, 3, and 6 hours postprandial
Gut microbiota
大体时间:single time point
Gut microbiota composition and gene content will be assessed in stool using polymerase chain reaction (PCR) and sequencing
single time point
Gut microbiota fermentation capacity
大体时间:single time point
The fermentation capacity of microbiota will be measured from a single stool sample
single time point
Gut microbiota pathogen resistance capacity
大体时间:single time point
The pathogen resistance capability of microbiota will be measured from a single stool sample
single time point
Gut inflammation
大体时间:single time point
Gut inflammation will be assessed by measuring molecules in stool and/or the response of intestinal epithelial cell cultures to fecal waters from a single stool sample.
single time point
Stool metabolites
大体时间:single time point
Volatile and short chain fatty acids and bile acids will be measured in a single stool sample.
single time point
Stool RNA markers
大体时间:single time point
RNA markers will provide a measure of genes expressed by cells of the colon naturally present in a single stool sample
single time point
Baseline and change in hunger and appetite
大体时间:0, 1, 2, 3, 4, 5, and 6 hours postprandial
Perceived hunger and fullness will be measured using a visual analog scale. Responses will be a marked on an unsegmented line from 0 or "not at all" to 5 or "extremely."
0, 1, 2, 3, 4, 5, and 6 hours postprandial
Baseline and change in gut fermentation profile
大体时间:0, 1, 2, 3, 4, 5, and 6 hours postprandial
Breath hydrogen and methane measured in response to a challenge meal.
0, 1, 2, 3, 4, 5, and 6 hours postprandial
Recent dietary intake
大体时间:Three 24-hour dietary recalls collected at home
Random selection of 2 week days and 1 weekend day for 24-hour recall using an automated multi-pass method
Three 24-hour dietary recalls collected at home
Dietary intake
大体时间:single time point
Food frequency questionnaire (FFQ)
single time point
Behavior assessment
大体时间:single time point
Chronic stress questionnaire, food choice questionnaires, and a food preference activity.
single time point
Taste thresholds
大体时间:single time point
Sampling tastes of sweet, salty, and bitter solutions in comparison to water to determine threshold of taste detection.
single time point
Skin reflectance
大体时间:single time point
Spectrophotometric measure of skin pigmentation for assessment of vitamin D status.
single time point
Peripheral arterial tone
大体时间:single time point
Use of the EndoPAT system to measure blood vessel tone.
single time point
Pulmonary function
大体时间:single time point
Forced expiratory lung volume test
single time point
Pulmonary inflammation
大体时间:single time point
Pulmonary inflammation measured as exhaled nitric oxide (NO)
single time point
Executive function
大体时间:single time point
Executive function will be assessed using Cambridge Neuropsychological Test Automated Battery (CANTAB) and Iowa Gambling Task
single time point
Cognitive function
大体时间:single time point
Measured by Wechsler Abbreviated Standard Intelligence test.
single time point
Aerobic fitness assessment
大体时间:single time point
Pulse rate (bpm) and recovery after a 3 min YMCA Step Test
single time point
Submaximal oxygen consumption
大体时间:single time point
The submaximal volume of oxygen consumed during a 4 minute treadmill walking protocol (VO2max) (ml/kg*min)
single time point
Physical activity
大体时间:daily, for 7 days
Use of an accelerometer worn on the hip for 7 days
daily, for 7 days
Usual physical activity
大体时间:single time point
Activity recall using a questionnaire
single time point
Heart rate variability and autonomic nerve conductivity
大体时间:single time point
Monitoring of autonomic balance, cardiac performance, and respiratory measurements and activity using MindWare Mobile Impedance Cardiograph.
single time point
Allostatic Load
大体时间:single time point
An aggregate score derived from measures of urinary cortisol, norepinephrine, epinephrine, blood cholesterol, high sensitivity c-reactive protein, and hemoglobin A1C.
single time point
Baseline and change in salivary cortisol in response to test meal
大体时间:0, immediately post-prandial, 30, 60, and 90 minutes post-prandial
Salivary cortisol measured by enzyme-linked immunosorbent assay (ELISA)
0, immediately post-prandial, 30, 60, and 90 minutes post-prandial
Baseline and change in salivary cortisol in response to exercise
大体时间:0, immediately post-exercise, 30, 60, and 90 minutes post-exercise
Salivary cortisol measured by enzyme-linked immunosorbent assay (ELISA)
0, immediately post-exercise, 30, 60, and 90 minutes post-exercise
Baseline and change in salivary cortisol in response to emotional recall task
大体时间:0, immediately post-task, 30, 60, and 90 minutes post-task
Salivary cortisol measured by enzyme-linked immunosorbent assay (ELISA)
0, immediately post-task, 30, 60, and 90 minutes post-task
Baseline and change in breath aldehydes
大体时间:0, 1, 4 and 6 hours postprandial
The concentration of aldehydes present in human breath before and after a high-fat meal will be measured by mass spectrometry
0, 1, 4 and 6 hours postprandial

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Charles B Stephensen, Ph.D.、USDA, Western Human Nutrition Research Center
  • 首席研究员:Brian J Bennett, Ph.D.、USDA, Western Human Nutrition Research Center

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

有用的网址

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2015年5月1日

初级完成 (实际的)

2019年7月24日

研究完成 (实际的)

2019年7月24日

研究注册日期

首次提交

2015年2月12日

首先提交符合 QC 标准的

2015年2月19日

首次发布 (估计)

2015年2月20日

研究记录更新

最后更新发布 (实际的)

2021年3月30日

上次提交的符合 QC 标准的更新

2021年3月25日

最后验证

2021年3月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • 691654
  • 2032-53000-001-00 (其他赠款/资助编号:United States Department of Agriculture)

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

3
订阅